Role of alpha blocker and steroid in better and early clearance of kidney and ureteric stones after extracorporeal lithotripsy
- Conditions
- Health Condition 1: null- PATIENTS WITH RENAL AND URETERIC CALCULUS SEEKING ELECTIVE PROCEDURE
- Registration Number
- CTRI/2018/04/013187
- Lead Sponsor
- SIR GANGA RAM HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 143
1.Renal or ureteric calculi proved on plain kidney, ureter, and bladder (KUB) radiography and ultrasonography of the kidney and confirmed with intravenous urogram or CT scan
2.Size between 6 to 15 mm in major axis.
3.Solitary renal / ureteric calculus
1.History of urinary tract surgery or endoscopic treatment
2.History of Concomitant treatment with alpha blockers, calcium channel blockers, or steroids
3.Morbid obesity (BMI >30)
4.History of previous failed ESWL
5.Patients with diabetes mellitus and hypertension
6.Active Urinary tract infection
7.Uncorrected Coagulopathy
8.Pregnant patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. To evaluate the efficacy of tamsulosin with or without deflazacort vs no treatment in terms of expulsion rate and expulsion time of stone fragments in renal or ureteric calculus after ESWL. <br/ ><br> <br/ ><br>2. To evaluate the effect of tamsulosin with or without deflazacort administration on frequency of analgesic use for relief of ureteric colic in renal or ureteric calculus after ESWL. <br/ ><br>Timepoint: Patients will be assessed after every 10 days upto maximum of 60 days <br/ ><br>
- Secondary Outcome Measures
Name Time Method To evaluate the effect of tamsulosin with or without deflazacort administration on frequency of analgesic use for relief of ureteric colic in renal or ureteric calculus after ESWL. <br/ ><br>Timepoint: Patients will be assessed after every 10 days upto maximum of 60 days